封面
市场调查报告书
商品编码
1538433

药品折扣卡市场报告:2030 年趋势、预测与竞争分析

Drug Discount Card Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

药品折扣卡趋势与预测

到 2030 年,全球药品折扣卡市场预计将达到 247 亿美元,2024 年至 2030 年复合年增长率为 8.2%。该市场的主要驱动因素是网上药局的激增和处方药价格的上涨。全球药品折扣卡市场的未来看起来充满希望,心血管、糖尿病、止痛药、精神科和癌症市场都有机会。

按细分市场分類的药品折扣卡

该研究包括按类型、销售管道、治疗类别和地区对全球药品折扣卡的预测。

药品折扣卡市场洞察

Lucintel 预测,品牌药品卡将在预测期内实现高速成长。

在这个市场中,心血管疾病药物预计将经历最高的成长。

预计北美地区在预测期内将出现最高的成长。

常问问题

Q1.市场规模为:

A1. 到 2030 年,全球药品折扣卡市场预计将达到 247 亿美元。

Q2.市场成长预测是多少:

A2. 2024年至2030年,全球药品折扣卡市场预计将以8.2%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是:

A3.该市场的主要驱动力是网路药局的渗透率不断提高以及处方笺药成本的上升。

Q4.市场的主要细分市场是:

A4. 医药优惠卡市场前景广阔,心血管疾病、糖尿病、止痛药、心理健康、癌症药物市场都有机会。

Q5.市场的主要企业是:

A5. 主要的药品折扣卡公司如下:

  • GoodRx
  • SingleCare
  • WellCard Savings
  • RxSaver
  • Optum Perks
  • Kroger Prescription Savings Club
  • ScriptSave
  • Walmart Rx Savings Program
  • Prescription Hope
  • FamilyWize

Q6.未来最大的细分市场是什么?

A6.Lucintel 预测,品牌药品卡将在预测期内实现高速成长。

Q7.未来五年预计哪个地区的市场成长最大?

A7. 预计北美地区在预测期内将出现最高成长。

Q8. 可以客製化报告吗?

A8. 是的,Lucintel 提供 10% 的客製化服务,无需额外付费。

目录

第一章执行摘要

第二章全球药品折扣卡市场:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势(2018-2023)与预测(2024-2030)
  • 全球药品折扣卡市场趋势(2018-2023)与预测(2024-2030)
  • 全球药品折扣卡市场:按类型
    • 品牌药卡
    • 学名药卡
  • 全球药品折扣卡市场:依销售管道
    • 在线的
    • 离线
  • 全球药品折扣卡市场:依治疗类别
    • 心血管疾病药物
    • 糖尿病药物
    • 镇痛剂
    • 心理健康药物
    • 癌症治疗药物
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球药品折扣卡市场(按地区)
  • 北美药品折扣卡市场
  • 欧洲药品折扣卡市场
  • 亚太药品折扣卡市场
  • 其他地区医药优惠卡市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
  • 全球药品折扣卡市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球医药折扣卡市场容量扩张
    • 全球医药折扣卡市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • GoodRx
  • SingleCare
  • WellCard Savings
  • RxSaver
  • Optum Perks
  • Kroger Prescription Savings Club
  • ScriptSave
  • Walmart Rx Savings Program
  • Prescription Hope
  • FamilyWize
简介目录

Drug Discount Card Trends and Forecast

The future of the global drug discount card market looks promising with opportunities in the cardiovascular drug, diabetes drug, pain medication, mental health medication, and cancer drug markets. The global drug discount card market is expected to reach an estimated $24.7 billion by 2030 with a CAGR of 8.2% from 2024 to 2030. The major drivers for this market are rising online adoption of online pharmacy and increasing cost of prescription medications.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Drug Discount Card by Segment

The study includes a forecast for the global drug discount card by type, sales channel, therapeutic category, and region.

Drug Discount Card Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Branded Cards
  • Generic Cards

Drug Discount Card Market by Sales Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Online
  • Offline

Drug Discount Card Market by Therapeutic Category [Shipment Analysis by Value from 2018 to 2030]:

  • Cardiovascular Drug
  • Diabetes Drug
  • Pain Medication
  • Mental Health Medication
  • Cancer Drug
  • Others

Drug Discount Card Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Drug Discount Card Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies drug discount card companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug discount card companies profiled in this report include-

  • GoodRx
  • SingleCare
  • WellCard Savings
  • RxSaver
  • Optum Perks
  • Kroger Prescription Savings Club
  • ScriptSave
  • Walmart Rx Savings Program
  • Prescription Hope
  • FamilyWize

Drug Discount Card Market Insights

Lucintel forecasts that branded card is expected to witness higher growth over the forecast period.

Within this market, cardiovascular drug is expected to witness the highest growth.

North America is expected to witness the highest growth over the forecast period.

Features of the Global Drug Discount Card Market

Market Size Estimates: Drug discount card market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Drug discount card market size by type, sales channel, therapeutic category, and region in terms of value ($B).

Regional Analysis: Drug discount card market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, sales channels, therapeutic categories, and regions for the drug discount card market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the drug discount card market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the drug discount card market size?

Answer: The global drug discount card market is expected to reach an estimated $24.7 billion by 2030.

Q2. What is the growth forecast for drug discount card market?

Answer: The global drug discount card market is expected to grow with a CAGR of 8.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the drug discount card market?

Answer: The major drivers for this market are rising online adoption of online pharmacy and increasing cost of prescription medications.

Q4. What are the major segments for drug discount card market?

Answer: The future of the drug discount card market looks promising with opportunities in the cardiovascular drug, diabetes drug, pain medication, mental health medication, and cancer drug markets.

Q5. Who are the key drug discount card market companies?

Answer: Some of the key drug discount card companies are as follows:

  • GoodRx
  • SingleCare
  • WellCard Savings
  • RxSaver
  • Optum Perks
  • Kroger Prescription Savings Club
  • ScriptSave
  • Walmart Rx Savings Program
  • Prescription Hope
  • FamilyWize

Q6. Which drug discount card market segment will be the largest in future?

Answer: Lucintel forecasts that branded card is expected to witness higher growth over the forecast period.

Q7. In drug discount card market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the drug discount card market by type (branded cards and generic cards), sales channel (online and offline), therapeutic category (cardiovascular drug, diabetes drug, pain medication, mental health medication, cancer drug, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Drug Discount Card Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Drug Discount Card Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Drug Discount Card Market by Type
    • 3.3.1: Branded Cards
    • 3.3.2: Generic Cards
  • 3.4: Global Drug Discount Card Market by Sales Channel
    • 3.4.1: Online
    • 3.4.2: Offline
  • 3.5: Global Drug Discount Card Market by Therapeutic Category
    • 3.5.1: Cardiovascular Drug
    • 3.5.2: Diabetes Drug
    • 3.5.3: Pain Medication
    • 3.5.4: Mental Health Medication
    • 3.5.5: Cancer Drug
    • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Drug Discount Card Market by Region
  • 4.2: North American Drug Discount Card Market
    • 4.2.1: North American Drug Discount Card Market by Type: Branded Cards and Generic Cards
    • 4.2.2: North American Drug Discount Card Market by Therapeutic Category: Cardiovascular drug, Diabetes drug, Pain medication, Mental health medication, Cancer drug, and Others
  • 4.3: European Drug Discount Card Market
    • 4.3.1: European Drug Discount Card Market by Type: Branded Cards and Generic Cards
    • 4.3.2: European Drug Discount Card Market by Therapeutic Category: Cardiovascular drug, Diabetes drug, Pain medication, Mental health medication, Cancer drug, and Others
  • 4.4: APAC Drug Discount Card Market
    • 4.4.1: APAC Drug Discount Card Market by Type: Branded Cards and Generic Cards
    • 4.4.2: APAC Drug Discount Card Market by Therapeutic Category: Cardiovascular drug, Diabetes drug, Pain medication, Mental health medication, Cancer drug, and Others
  • 4.5: ROW Drug Discount Card Market
    • 4.5.1: ROW Drug Discount Card Market by Type: Branded Cards and Generic Cards
    • 4.5.2: ROW Drug Discount Card Market by Therapeutic Category: Cardiovascular drug, Diabetes drug, Pain medication, Mental health medication, Cancer drug, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Drug Discount Card Market by Type
    • 6.1.2: Growth Opportunities for the Global Drug Discount Card Market by Sales Channel
    • 6.1.3: Growth Opportunities for the Global Drug Discount Card Market by Therapeutic Category
    • 6.1.4: Growth Opportunities for the Global Drug Discount Card Market by Region
  • 6.2: Emerging Trends in the Global Drug Discount Card Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Drug Discount Card Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Drug Discount Card Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: GoodRx
  • 7.2: SingleCare
  • 7.3: WellCard Savings
  • 7.4: RxSaver
  • 7.5: Optum Perks
  • 7.6: Kroger Prescription Savings Club
  • 7.7: ScriptSave
  • 7.8: Walmart Rx Savings Program
  • 7.9: Prescription Hope
  • 7.10: FamilyWize